- Messages
- 2,125
I posted the website address on a previous thread:
http://www.ukrituximabtrial.org/
The Invest in ME UK Rituximab Clinical Trial and B-cell Studies
Welcome to the UK rituximab trial Home page
Invest in ME is a UK charity campaigning for a strategy of biomedical research into Myalgic Encephalomyelitis (ME) and promoting better education about ME.
This website describes the UK rituximab trial project and related B-cell study research which Invest in ME has initiated and has been organising since the international biomedical researchers meeting and conference which the charity organised on 30/31 May 2013 and which was announced on Invest in ME website on 6th June.
We are doing this to further advance biomedical research into ME and provide hope for some to regain their lives, and for others to benefit from improved knowledge about this disease.
“Looking at the research directions currently being pursued in ME/CFS, I am in no doubt that the usage of rituximab is one of the most promising.”
- Emeritus Professor Jonathan Edwards
“Invest in ME are at the forefront of international biomedical research and have by sheer determination and effort managed to put things in place for a trial of rituximab to begin on ME patients in the UK.”
- Professor Malcolm Hooper & Margaret William
http://www.ukrituximabtrial.org/
The Invest in ME UK Rituximab Clinical Trial and B-cell Studies
Welcome to the UK rituximab trial Home page
Invest in ME is a UK charity campaigning for a strategy of biomedical research into Myalgic Encephalomyelitis (ME) and promoting better education about ME.
This website describes the UK rituximab trial project and related B-cell study research which Invest in ME has initiated and has been organising since the international biomedical researchers meeting and conference which the charity organised on 30/31 May 2013 and which was announced on Invest in ME website on 6th June.
We are doing this to further advance biomedical research into ME and provide hope for some to regain their lives, and for others to benefit from improved knowledge about this disease.
“Looking at the research directions currently being pursued in ME/CFS, I am in no doubt that the usage of rituximab is one of the most promising.”
- Emeritus Professor Jonathan Edwards
“Invest in ME are at the forefront of international biomedical research and have by sheer determination and effort managed to put things in place for a trial of rituximab to begin on ME patients in the UK.”
- Professor Malcolm Hooper & Margaret William